Literature DB >> 12928127

Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.

Marina S Savchenko1, Alexandr V Bazhin, Olga N Shifrina, Sofia A Demoura, Eugenia A Kogan, Alexandr G Chuchalin, Pavel P Philippov.   

Abstract

The goal of the present study was to analyze serum and tumor tissue of a patient with non-small cell lung cancer (NSCLC) for the presence of autoantibodies against recoverin (anti-Rc) and recoverin expression, correspondingly. Using immunoblotting with recombinant recoverin as an antigen, we have detected anti-Rc in serum of the patient. At the same time, the patient did not manifest any signs of cancer-associated retinopathy (CAR). Polyclonal (monospecific) antibodies against recoverin used for immunohistochemical analysis of the patient's tumor revealed recoverin expression in the tumor sections. To our knowledge, this is the first case of the presence of serum anti-Rc in NSCLC patients in the absence of paraneoplastic retina degeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928127     DOI: 10.1016/s0169-5002(03)00239-3

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  11 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy.

Authors:  Grazyna Adamus; Rachel Champaigne; Sufang Yang
Journal:  Clin Immunol       Date:  2019-11-23       Impact factor: 3.969

3.  Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

Authors:  Grazyna Adamus
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-09       Impact factor: 4.799

Review 4.  Non-paraneoplastic related retinopathy: clinical challenges and review.

Authors:  Júlia T Takiuti; Vitor K L Takahashi; Christine L Xu; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2019-08-08       Impact factor: 1.803

5.  Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases.

Authors:  Marina S Savchenko; Maria A Goncharskaia; Elena E Skorikova; Stefan B Eichmüller; Nikolay E Kushlinsky; Alexandr V Bazhin; Pavel P Philippov
Journal:  Oncol Lett       Date:  2011-10-31       Impact factor: 2.967

6.  Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration.

Authors:  Stephanie C Joachim; Kai Bruns; Karl J Lackner; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-13       Impact factor: 3.535

Review 7.  Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review.

Authors:  Bin Yang; Xiaoyan Li; Tianyi Ren; Yiyu Yin
Journal:  Cell Death Discov       Date:  2019-08-05

8.  [Antineuronal antibodies: Anti-recoverin in neurological syndromes without retinopathy. SARS-CoV2 infection as a trigger].

Authors:  G M Ávila; E E Escamilla; A P González; J A M Corral; C P Fernández; A R Marcos
Journal:  Neurologia       Date:  2021-08-02       Impact factor: 5.486

9.  Cancer-associated retinopathy in patients with breast carcinoma.

Authors:  Marta Misiuk-Hojło; Maria Ejma; Wojciech A Gorczyca; Stanisław Szymaniec; Danuta Witkowska; Wojciech Fortuna; Ryszard Miedzybrodzki; Jadwiga Rogozińska-Szczepka; Wiesława Bartnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

10.  Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.

Authors:  Grazyna Adamus; Gaoying Ren; Richard G Weleber
Journal:  BMC Ophthalmol       Date:  2004-06-04       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.